Discontinuation report DILTIAZEM-CD
Report ID | 143087 |
Drug Identification Number | 02231474 |
Brand name | DILTIAZEM-CD |
Common or Proper name | DILTIAZEM-CD |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 180MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-07-27 |
Remaining supply date | 2022-03-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-08-12 | French | Compare |
v3 | 2021-08-12 | English | Compare |
v2 | 2021-07-27 | French | Compare |
v1 | 2021-07-27 | English | Compare |
Showing 1 to 4 of 4